Steigerwald Gordon & Koch’s UnitedHealth UNH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$335K Sell
807
-30
-4% -$11.1K 0.03% 112
2026
Q1
$226K Sell
837
-98
-10% -$29.2K 0.02% 128
2025
Q4
$309K Sell
935
-121
-11% -$41K 0.03% 111
2025
Q3
$365K Sell
1,056
-81
-7% -$24.5K 0.04% 102
2025
Q2
$355K Sell
1,137
-145
-11% -$55.4K 0.04% 94
2025
Q1
$671K Sell
1,282
-10
-0.8% -$5.11K 0.07% 72
2024
Q4
$654K Sell
1,292
-8
-0.6% -$4.54K 0.07% 75
2024
Q3
$760K Sell
1,300
-42
-3% -$23.8K 0.08% 71
2024
Q2
$684K Sell
1,342
-58
-4% -$28.4K 0.08% 69
2024
Q1
$693K Buy
1,400
+1
+0.1% +$508 0.09% 70
2023
Q4
$737K Buy
1,399
+212
+18% +$113K 0.1% 67
2023
Q3
$598K Buy
1,187
+16
+1% +$7.87K 0.09% 69
2023
Q2
$563K Buy
1,171
+95
+9% +$46.5K 0.08% 72
2023
Q1
$508K Buy
1,076
+13
+1% +$6.27K 0.08% 75
2022
Q4
$564K Buy
1,063
+8
+0.8% +$4.24K 0.09% 73
2022
Q3
$533K Buy
1,055
+18
+2% +$9.46K 0.1% 69
2022
Q2
$533K Buy
1,037
+145
+16% +$72.8K 0.09% 73
2022
Q1
$455K Buy
892
+3
+0.3% +$1.45K 0.07% 81
2021
Q4
$446K Buy
889
+12
+1% +$5.43K 0.07% 80
2021
Q3
$343K Buy
877
+50
+6% +$20.7K 0.06% 87
2021
Q2
$331K Sell
827
-15
-2% -$5.98K 0.05% 87
2021
Q1
$313K Buy
842
+10
+1% +$3.46K 0.06% 87
2020
Q4
$292K Buy
832
+68
+9% +$22.8K 0.06% 87
2020
Q3
$238K Buy
+764
New +$235K 0.06% 92
2020
Q1
Sell
-815
Closed -$240K 89
2019
Q4
$240K Buy
+815
New +$213K 0.06% 83
2019
Q2
Sell
-814
Closed -$201K 85
2019
Q1
$201K Sell
814
-60
-7% -$15.3K 0.05% 81
2018
Q4
$218K Hold
874
0.06% 78
2018
Q3
$233K Sell
874
-190
-18% -$49.4K 0.06% 79
2018
Q2
$212K Buy
+1,064
New +$255K 0.06% 82
2018
Q1
Sell
-1,164
Closed -$257K 88
2017
Q4
$257K Sell
1,164
-130
-10% -$27.6K 0.07% 71
2017
Q3
$253K Sell
1,294
-115
-8% -$22.2K 0.07% 75
2017
Q2
$261K Buy
1,409
+45
+3% +$7.89K 0.07% 74
2017
Q1
$224K Sell
1,364
-35
-3% -$5.73K 0.07% 78
2016
Q4
$224K Buy
+1,399
New +$209K 0.07% 74

Other funds holding UNH

Steigerwald Gordon & Koch's UNH Position: Q2 2026 in Review

Steigerwald Gordon & Koch reduced its UnitedHealth (UNH) stake by 3.6% in Q2 2026, selling an estimated $11.1K and leaving 807 shares worth $335K. The position accounts for 0.03% of the portfolio, ranked #112.

Steigerwald Gordon & Koch first reported a position in UNH in Q4 2016 and has held it in 34 quarters since. The position peaked at $760K in Q3 2024. 1,742 funds tracked by Wall St. Rank hold UNH as of Q2 2026.

  • Steigerwald Gordon & Koch held 807 shares of UnitedHealth worth $335K as of Q2 2026.
  • Steigerwald Gordon & Koch sold 30 UnitedHealth shares in Q2 2026, an estimated $11.1K.
  • UnitedHealth made up 0.03% of Steigerwald Gordon & Koch's portfolio in Q2 2026, its #112 holding.
  • Steigerwald Gordon & Koch first reported a position in UnitedHealth in Q4 2016 and has held it in 34 quarters since.
  • Steigerwald Gordon & Koch's UnitedHealth position peaked at $760K in Q3 2024.
  • 1,742 funds tracked by Wall St. Rank held UnitedHealth as of Q2 2026.

Based on Steigerwald Gordon & Koch's 13F filing for Q2 2026, filed 23 Jul 2026.